Medications

2nd firm agrees to temporary shutdown in outbreak

(AP)—A Massachusetts company run by the same executives who operated a specialty pharmacy linked to a fatal meningitis outbreak has agreed to temporarily shut down for inspection by state and federal regulators.

Diseases, Conditions, Syndromes

US: Avoid drugs from company tied to meningitis (Update)

U.S. health officials ramped up warnings Thursday about a specialty pharmacy linked to a widening outbreak of a rare kind of meningitis, urging doctors and hospitals not to use any products from the company.

Medications

Anti-clot drug recommended for new approval in EU

(AP)—Advisers to European Union regulators have recommended approval of a new anti-clotting drug for use by adults with a common irregular heart rhythm that boosts risk of strokes or blood clots, drugmakers Bristol-Myers ...

Health

Genetically engineered rice: Protection from arsenic?

(Medical Xpress)—In an article this week, Consumer Reports is calling on the Food and Drug Administration to set standards for how much arsenic can be allowed in rice after finding the potential toxin in almost every rice ...

Medications

New online tool helps industry identify drug interactions

Drug interactions and drug side effects occur all-too-often in patients' lives. Now there's a new online resource to help guide pharmaceutical developers as they endeavor to improve testing for potentially harmful drug interactions ...

HIV & AIDS

US approves new once-a-day pill to treat HIV (Update)

A new pill to treat HIV infection—combining two previously approved drugs plus two new ones—has been approved for adults living with the virus that causes AIDS, US regulators said Monday.

Medications

In drug-approval race, US FDA ahead of Canada, Europe

The U.S. Food and Drug Administration (FDA) generally approves drug therapies faster and earlier than its counterparts in Canada and Europe, according to a new study by Yale School of Medicine researchers. The study counters ...

page 16 from 18